Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.

American journal of kidney diseases : the official journal of the National Kidney Foundation - 1 Sept 2015

Riella Leonardo V, Sheridan Alice M

Abstract excerpt

Accurate risk assessment is critical when evaluating potential living kidney donors. High-risk kidney APOL1 variants have been associated with end-stage renal disease of multiple causes among African Americans, though the predictive power of these variants in population-based studies is small. No studies have looked at the effect of high-risk APOL1 alleles on donor outcomes, though few transplantation centers in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein L1
Share to Apolipoproteins
Share to Donor Selection

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kidney Failure, Chronic

Share to Kidney Transplantation

Share to Lipoproteins, HDL

Share to Living Donors

Share to Renal Insufficiency, Chronic

Source

Identifiers

PMID: 26049628
DOI: 10.1053/j.ajkd.2015.04.046

Genes

APOL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.PMID 26049628Read ↗

African American living-kidney donors should be screened for APOL1 risk alleles.Semantic proximity Read ↗

Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation: ApoL1 as a Case Study.Semantic proximity Read ↗

Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference.Semantic proximity Read ↗

APOL1 Genotyping in Potential African American Living Kidney Donors: Utility and Cost-Effectiveness.Semantic proximity Read ↗

Apolipoprotein L1: role in the evaluation of kidney transplant donors.Semantic proximity Read ↗

Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion.Semantic proximity Read ↗

Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.Semantic proximity Read ↗

Evaluation of Potential Living Kidney Donors in the APOL1 EraSemantic proximity Read ↗

The evolving science of apolipoprotein-L1 and kidney disease.Semantic proximity Read ↗

Clinical Genetic Testing for APOL1: Are we There Yet?Semantic proximity Read ↗

Should kidney donors be genotyped for APOL1 risk alleles?Semantic proximity Read ↗

Apolipoprotein L1 Gene Effects on Kidney Transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.